Kazia Therapeutics Limited(KZIA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KZIA Kazia Therapeutics Limited

盘前交易 02-18 08:27:40 EST

5.34

+0.33

+6.59%

盘前5.43

+0.09+1.69%

08:24 EST

最高5.50	最低4.91	成交量13.64万
今开5.08	昨收5.01	日振幅11.78%
总市值6,053万	流通市值5,652万	总股本1,134万
成交额71.90万	换手率1.29%	流通股本1,058万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"KZIA","market":"US","secType":"STK","nameCN":"Kazia Therapeutics Limited","latestPrice":5.34,"timestamp":1771362000000,"preClose":5.01,"halted":0,"volume":136421,"hourTrading":{"tag":"盘前","latestPrice":5.43,"preClose":5.34,"latestTime":"08:24 EST","volume":18,"amount":105.899994,"timestamp":1771421041122,"change":0.09,"changeRate":0.016854,"amplitude":0.089888},"delay":0,"changeRate":0.06586826347305391,"floatShares":10583400,"shares":11336000,"eps":-12.38492,"marketStatus":"盘前交易","change":0.33,"latestTime":"02-18 08:27:40 EST","open":5.08,"high":5.5,"low":4.91,"amount":719048.8026733,"amplitude":0.117764,"askPrice":5.77,"askSize":200,"bidPrice":4.74,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-12.38492,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771425000000},"marketStatusCode":1,"adr":0,"adrRate":500,"exchange":"NASDAQ","adjPreClose":5.34,"preHourTrading":{"tag":"盘前","latestPrice":5.43,"preClose":5.34,"latestTime":"08:24 EST","volume":18,"amount":105.899994,"timestamp":1771421041122,"change":0.09,"changeRate":0.016854,"amplitude":0.089888},"postHourTrading":{"tag":"盘后","latestPrice":5.34,"preClose":5.34,"latestTime":"18:40 EST","volume":119,"amount":645.97,"timestamp":1771371604323,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.876533214602646,"impliedVol":2.737,"impliedVolPercentile":0.7636},"requestUrl":"/m/hq/s/KZIA/tweets","defaultTab":"tweets","newsList":[{"id":"2612146763","title":"Kazia Therapeutics Limited盘中异动 临近午盘急速拉升5.59%报5.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612146763","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612146763?lang=zh_cn&edition=full","pubTime":"2026-02-18 00:33","pubTimestamp":1771346025,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日00时33分，Kazia Therapeutics Limited股票出现波动，股价快速拉升5.59%。截至发稿，该股报5.29美元/股，成交量3.5977万股，换手率0.32%，振幅6.30%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.25%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤药物开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021800334597a66892&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021800334597a66892&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","NVGNF","BK4007","KZIA"],"gpt_icon":0},{"id":"1112652718","title":"Kazia Therapeutics公布核内Pd-L1降解剂Ndl2引人注目的临床前及转化研究数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1112652718","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112652718?lang=zh_cn&edition=full","pubTime":"2026-01-30 21:02","pubTimestamp":1769778174,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Limited (简称Kazia) 近日发布了其核内Pd-L1降解剂候选药物Ndl2的最新研究进展。数据显示，该药物在临床前及转化研究阶段展现出令人鼓舞的潜力。\n研究结果突显了Ndl2在靶向核内Pd-L1蛋白降解方面的独特机制。这些发现为后续开发提供了坚实的科学依据，并预示着该疗法在相关疾病领域可能具有重要的应用价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"gpt_icon":0},{"id":"1124170363","title":"Kazia Therapeutics Limited 目标在2026年底前招募12名三阴性乳腺癌患者，并于2027年初公布顶线数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1124170363","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124170363?lang=zh_cn&edition=full","pubTime":"2026-01-27 21:02","pubTimestamp":1769518977,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Limited 已设定明确目标，计划在2026年年底前完成12名三阴性乳腺癌（TNBC）患者的入组工作。这项临床研究的顶线数据预计将在2027年初揭晓，标志着该药物研发项目的一个重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZIA","BK4139"],"gpt_icon":0},{"id":"1199188637","title":"Kazia Therapeutics在晚期转移性三阴性乳腺癌Paxalisib一期B阶段研究中报告积极初步临床反应","url":"https://stock-news.laohu8.com/highlight/detail?id=1199188637","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199188637?lang=zh_cn&edition=full","pubTime":"2026-01-27 21:01","pubTimestamp":1769518875,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Limited（简称：Kazia）在其针对晚期转移性三阴性乳腺癌患者开展的Paxalisib药物一期B阶段临床研究中，公布了令人鼓舞的初步临床反应数据。该研究目前仍在进行中，最新结果显示Paxalisib在治疗这一难治型癌症方面展现出潜在疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZIA","BK4139"],"gpt_icon":0},{"id":"2586491079","title":"Kazia Therapeutics Limited盘中异动 股价大跌7.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586491079","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586491079?lang=zh_cn&edition=full","pubTime":"2025-11-24 23:49","pubTimestamp":1763999395,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日23时49分，Kazia Therapeutics Limited股票出现异动，股价急速跳水7.78%。截至发稿，该股报7.70美元/股，成交量3.1636万股，换手率1.89%，振幅6.57%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.79%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242349569517c089&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242349569517c089&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4007","NVGNF","LENZ","KZIA"],"gpt_icon":0},{"id":"1148748436","title":"Kazia Therapeutics有限公司就Paxalisib的项目领跑者寻求FDA的反馈","url":"https://stock-news.laohu8.com/highlight/detail?id=1148748436","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148748436?lang=zh_cn&edition=full","pubTime":"2025-10-27 19:21","pubTimestamp":1761564082,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics有限公司就Paxalisib的项目领跑者寻求FDA的反馈","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"gpt_icon":0},{"id":"1148501573","title":"Kazia Therapeutics计划请求FDA进行类型C会议，以讨论GBM的总体生存数据及潜在的NDA申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1148501573","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148501573?lang=zh_cn&edition=full","pubTime":"2025-10-27 19:16","pubTimestamp":1761563768,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics计划请求FDA进行类型C会议，讨论于胶质母细胞瘤（GBM）中的总体生存数据，以及与FDA倡议项目“先锋者”（Project Frontrunner）相一致的潜在NDA申请。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"gpt_icon":0},{"id":"2573747981","title":"Kazia Therapeutics Limited盘中异动 大幅拉升5.03%报6.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2573747981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573747981?lang=zh_cn&edition=full","pubTime":"2025-10-07 00:26","pubTimestamp":1759767972,"startTime":"0","endTime":"0","summary":"北京时间2025年10月07日00时26分，Kazia Therapeutics Limited股票出现波动，股价大幅上涨5.03%。截至发稿，该股报6.89美元/股，成交量2.8339万股，换手率1.70%，振幅5.79%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体跌幅为0.36%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251007002612a6aefc85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251007002612a6aefc85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","NVGNF","KZIA","BK4007"],"gpt_icon":0},{"id":"1111503317","title":"Kazia Therapeutics Limited宣布：Paxalisib联合免疫疗法使三阴性乳腺癌患者肿瘤缩小86%","url":"https://stock-news.laohu8.com/highlight/detail?id=1111503317","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111503317?lang=zh_cn&edition=full","pubTime":"2025-10-02 20:33","pubTimestamp":1759408393,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Limited宣布：Paxalisib联合免疫疗法使三阴性乳腺癌患者肿瘤缩小86%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"gpt_icon":0},{"id":"1118445009","title":"Kazia Therapeutics Limited股价盘前大涨56% 公司乳腺癌疗法成功破坏肿瘤细胞簇","url":"https://stock-news.laohu8.com/highlight/detail?id=1118445009","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118445009?lang=zh_cn&edition=full","pubTime":"2025-09-11 20:26","pubTimestamp":1757593573,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics Limited股价在盘前交易中飙升56%，此前该公司宣布其乳腺癌治疗方案在破坏肿瘤细胞簇方面取得突破性进展。这一积极消息推动了投资者对该生物技术公司前景的乐观情绪，股价出现大幅上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KZIA","BK4139"],"gpt_icon":0},{"id":"1123909779","title":"Kazia Therapeutics宣布Paxalisib单药疗法在IV期HER2阳性乳腺癌中完全破坏大型循环肿瘤细胞集群的体外研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1123909779","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123909779?lang=zh_cn&edition=full","pubTime":"2025-09-11 20:01","pubTimestamp":1757592079,"startTime":"0","endTime":"0","summary":"Kazia Therapeutics宣布Paxalisib单药疗法在IV期HER2阳性乳腺癌中完全破坏大型循环肿瘤细胞集群的体外研究结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KZIA"],"gpt_icon":0},{"id":"2563834498","title":"Kazia Therapeutics Limited盘中异动 股价大涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563834498","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563834498?lang=zh_cn&edition=full","pubTime":"2025-08-30 00:04","pubTimestamp":1756483462,"startTime":"0","endTime":"0","summary":"北京时间2025年08月30日00时04分，Kazia Therapeutics Limited股票出现异动，股价快速拉升5.35%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Briacell Therapeutics Corp C/Wts 26/02/2026、Vivosim Labs, Inc.、Inflarx N.V.涨幅较大，Tnf Pharmaceuticals, Inc.、Vivosim Labs, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为36807.70%、263.62%、113.30%，振幅较大的相关个股有Vivosim Labs, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Relmada Therapeutics, Inc.，振幅分别为62.03%、56.67%、46.44%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508300004229505ee47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508300004229505ee47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","NVGNF","KZIA","BK4007"],"gpt_icon":0},{"id":"2518222567","title":"Kazia Therapeutics Limited盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518222567?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:36","pubTimestamp":1741613793,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时36分，Kazia Therapeutics Limited股票出现波动，股价大幅下挫5.08%。截至发稿，该股报1.12美元/股，成交量19.3999万股，换手率3.47%，振幅5.08%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.42%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213633abf2fe3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213633abf2fe3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","KZIA","NVGNF"],"gpt_icon":0},{"id":"2517161311","title":"Kazia Therapeutics Limited盘中异动 大幅拉升7.33%报0.848美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161311?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:59","pubTimestamp":1741273143,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时59分，Kazia Therapeutics Limited股票出现波动，股价急速拉升7.33%。截至发稿，该股报0.848美元/股，成交量1165股，换手率0.02%，振幅7.33%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体跌幅为0.63%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225903abeb7e9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225903abeb7e9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NVGNF","KZIA","BK4139"],"gpt_icon":0},{"id":"2517948806","title":"Kazia Therapeutics Limited盘中异动 股价大涨6.06%报0.810美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948806?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:32","pubTimestamp":1741185143,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时32分，Kazia Therapeutics Limited股票出现异动，股价大幅拉升6.06%。截至发稿，该股报0.810美元/股，成交量4.5971万股，换手率0.82%，振幅0.00%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.20%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223223abe9b0fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223223abe9b0fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVGNF","KZIA","LENZ","BK4139"],"gpt_icon":0},{"id":"2517833819","title":"Kazia Therapeutics Limited盘中异动 急速下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517833819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517833819?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:33","pubTimestamp":1741116814,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时33分，Kazia Therapeutics Limited股票出现波动，股价大幅跳水5.16%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Rapport Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Aeon Biopharma, Inc.、Protagenic Therapeutics, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为1311.19%、1224.04%、1209.16%，振幅较大的相关个股有Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Plus Therapeutics, Inc.，振幅分别为122.48%、68.89%、68.09%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305033334a25f57f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305033334a25f57f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVGNF","LENZ","KZIA"],"gpt_icon":0},{"id":"2514861729","title":"Kazia Therapeutics Limited盘中异动 急速上涨5.62%报0.864美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514861729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514861729?lang=zh_cn&edition=full","pubTime":"2025-02-27 03:38","pubTimestamp":1740598693,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时38分，Kazia Therapeutics Limited股票出现异动，股价急速上涨5.62%。截至发稿，该股报0.864美元/股，成交量3.8845万股，换手率0.69%，振幅5.28%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体跌幅为0.47%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270338139631862c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270338139631862c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KZIA","BK4139","NVGNF"],"gpt_icon":0},{"id":"2514016510","title":"Kazia Therapeutics Limited盘中异动 早盘股价大跌8.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514016510?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:30","pubTimestamp":1740497415,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时30分，Kazia Therapeutics Limited股票出现异动，股价大幅下跌8.34%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1070.68%、947.53%、593.23%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp，振幅分别为121.95%、64.05%、61.16%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233015a253950e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233015a253950e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVGNF","LENZ","BK4139","KZIA"],"gpt_icon":0},{"id":"2512348187","title":"Kazia Therapeutics Limited盘中异动 急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512348187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512348187?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:02","pubTimestamp":1739980942,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时02分，Kazia Therapeutics Limited股票出现异动，股价急速下挫5.00%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为561.88%、242.60%、178.48%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Aditxt, Inc.，振幅分别为207.68%、159.49%、48.18%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220000223a24c0cd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220000223a24c0cd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","KZIA","NVGNF"],"gpt_icon":0},{"id":"2512659401","title":"Kazia Therapeutics Limited盘中异动 早盘大幅上涨7.81%报0.960美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512659401","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512659401?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889178,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，Kazia Therapeutics Limited股票出现异动，股价大幅上涨7.81%。截至发稿，该股报0.960美元/股，成交量9723股，换手率0.17%，振幅3.31%。Kazia Therapeutics Limited股票所在的生物技术行业中，整体涨幅为0.11%。Kazia Therapeutics Limited公司简介：Kazia Therapeutics Ltd是一家专注于肿瘤的生物技术公司，开发抗癌药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223258a24aad04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223258a24aad04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KZIA","BK4139","NVGNF","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kaziatherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.022},{"period":"1month","weight":-0.2542},{"period":"3month","weight":-0.3101},{"period":"6month","weight":-0.2685},{"period":"1year","weight":0.2},{"period":"ytd","weight":-0.225}],"compareEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":-0.0127},{"period":"3month","weight":0.0305},{"period":"6month","weight":0.0744},{"period":"1year","weight":0.12},{"period":"ytd","weight":0.0014}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kazia Therapeutics Limited成立于1994年3月，注册地为澳大利亚新南威尔士州。该公司从事药物开发，主要专注于肿瘤学。Kazia是一家新兴的生物技术企业，拥有涵盖多种技术的开发候选产品组合，旨在推进针对各种癌症适应症的创新疗法，并提供解决未满足的医疗需求的新疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.481481,"avgChangeRate":0.051769},{"month":2,"riseRate":0.25,"avgChangeRate":0.012599},{"month":3,"riseRate":0.518519,"avgChangeRate":0.052977},{"month":4,"riseRate":0.407407,"avgChangeRate":0.002336},{"month":5,"riseRate":0.296296,"avgChangeRate":-0.02903},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.056841},{"month":7,"riseRate":0.37037,"avgChangeRate":0.010347},{"month":8,"riseRate":0.407407,"avgChangeRate":0.002958},{"month":9,"riseRate":0.481481,"avgChangeRate":-0.003545},{"month":10,"riseRate":0.37037,"avgChangeRate":-0.038599},{"month":11,"riseRate":0.481481,"avgChangeRate":0.165037},{"month":12,"riseRate":0.407407,"avgChangeRate":-0.048165}],"exchange":"NASDAQ","name":"Kazia Therapeutics Limited","nameEN":"Kazia Therapeutics Limited"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kazia Therapeutics Limited(KZIA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kazia Therapeutics Limited(KZIA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kazia Therapeutics Limited,KZIA,Kazia Therapeutics Limited股票,Kazia Therapeutics Limited股票老虎,Kazia Therapeutics Limited股票老虎国际,Kazia Therapeutics Limited行情,Kazia Therapeutics Limited股票行情,Kazia Therapeutics Limited股价,Kazia Therapeutics Limited股市,Kazia Therapeutics Limited股票价格,Kazia Therapeutics Limited股票交易,Kazia Therapeutics Limited股票购买,Kazia Therapeutics Limited股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kazia Therapeutics Limited(KZIA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kazia Therapeutics Limited(KZIA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}